| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Nippon India Nifty Pharma ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.02 |
| Equity |
99.94 |
| Trep |
0.04 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
61.65% |
| Top 10 Holdings |
80.20% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.94 |
| Cash |
0.06 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.87 |
| PE Ratio |
32.11 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
24.97 |
| Cipla Limited |
10.78 |
| Dr Reddys Laboratories Limited |
9.85 |
| DIVI LABORATORIES LTD |
9.40 |
| Lupin Limited |
6.65 |
| Aurobindo Pharma Limited |
4.34 |
| Torrent Pharmaceuticals Limited |
4.07 |
| Alkem Laboratories Limited |
3.57 |
| MANKIND PHARMA LIMITED |
3.35 |
| Zydus Lifesciences Limited |
3.22 |
| Laurus Labs Limited |
3.05 |
| Glenmark Pharmaceuticals Limited |
2.90 |
| IPCA Laboratories Limited |
2.59 |
| Biocon Limited |
2.16 |
| Abbott India Limited |
1.80 |
| J B Chemicals and Pharma Ltd |
1.67 |
| Gland Pharma Limited |
1.61 |
| Ajanta Pharma Limited |
1.50 |
| Natco Pharma Limited |
1.39 |
| Granules India Limited |
1.07 |
| Triparty Repo |
0.04 |
| Net Current Assets |
0.02 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
